The global allergy diagnostics market size was valued at USD 7.09 billion in 2025 and is projected to reach USD 16.37 billion by 2033, growing at a CAGR of 11.29% from 2026 to 2033. The market is experiencing substantial growth due to the increasing prevalence of allergic disorders worldwide and the growing need for accurate, rapid, and reliable diagnostic solutions. The growth is driven by the rising incidence of conditions such as allergic rhinitis, asthma, atopic dermatitis, and food allergies, which are becoming more common due to environmental pollution, urbanization, and lifestyle changes.

Rising exposure to airborne pollutants, changing dietary habits, climate-related factors, and increased allergen sensitivity among individuals are contributing to the growing burden of allergic diseases. As healthcare providers increasingly focus on early diagnosis and personalized treatment approaches, demand for advanced allergy testing technologies continues to rise. In addition, advancements in molecular diagnostics, immunoassays, and laboratory automation are improving testing accuracy and efficiency, further supporting market expansion. Growing public awareness regarding allergy management and increasing healthcare expenditures are also creating favorable conditions for market growth during the forecast period.

Download a free sample copy of the Allergy Diagnostics market report to understand detailed coverage and inclusions in the final report

Key Market Trends & Insights

• North America allergy diagnostics market held the largest share of 36.62% of the global market in 2025. The region’s leading position can be attributed to the high prevalence of allergic diseases, well-established healthcare infrastructure, strong adoption of advanced diagnostic technologies, and increasing awareness among patients regarding allergy testing. The presence of major diagnostic companies, extensive research activities, and favorable reimbursement policies further contribute to market growth across the region. In addition, growing investments in healthcare innovation and the increasing availability of specialized allergy clinics are enhancing access to diagnostic services. The rising demand for personalized medicine and preventive healthcare strategies is also supporting the continued expansion of the allergy diagnostics market throughout North America.
• The allergy diagnostics industry in the U.S. is expected to grow significantly over the forecast period. The increasing number of individuals affected by respiratory allergies, food allergies, and skin-related allergic conditions is driving demand for accurate diagnostic testing. Growing awareness campaigns, improved access to healthcare services, and technological advancements in laboratory testing are supporting market development. Furthermore, healthcare providers are increasingly utilizing comprehensive allergy testing panels to identify specific allergens and develop targeted treatment plans, contributing to the industry's growth across the country.
• By products and services, the consumables segment held the highest market share of 63.21% in 2025. Consumables, including reagents, assay kits, test strips, and laboratory supplies, are essential components of allergy diagnostic procedures and are used repeatedly in testing laboratories and healthcare facilities. The growing volume of allergy testing procedures worldwide is increasing demand for these products. Continuous product innovation, expanding test menus, and the introduction of advanced diagnostic reagents are further strengthening the segment's position. As healthcare facilities continue to adopt high-throughput diagnostic systems, the need for reliable consumables is expected to remain strong over the forecast period.
• By allergen, the inhaled segment held the highest market share in 2025. Inhaled allergens such as pollen, dust mites, mold spores, animal dander, and airborne pollutants are among the most common triggers of allergic reactions worldwide. The increasing prevalence of respiratory allergies and asthma, particularly in urban areas with higher pollution levels, has significantly contributed to the dominance of this segment. Growing awareness about environmental allergens and the need for accurate identification of allergy triggers are driving the demand for inhaled allergen testing. The rising incidence of seasonal allergies and changing climatic conditions are also expected to support continued growth in this segment.
• By test type, the in-vitro segment held the highest market share in 2025. In-vitro allergy testing methods are widely preferred due to their accuracy, safety, convenience, and ability to evaluate multiple allergens simultaneously. These tests eliminate the risk of adverse reactions associated with certain skin testing procedures and are particularly beneficial for patients with severe allergies or specific medical conditions. Technological advancements in laboratory diagnostics and the growing adoption of automated testing platforms are enhancing the efficiency and reliability of in-vitro testing solutions. As healthcare providers increasingly prioritize precise and comprehensive allergy diagnosis, the demand for in-vitro testing is expected to remain strong.
• By end use, hospitals & clinics held the highest market share in 2025. Hospitals and clinics serve as primary centers for allergy diagnosis, patient evaluation, and treatment planning, making them major contributors to market revenue. The increasing number of patients seeking professional allergy assessment, coupled with the availability of advanced diagnostic equipment and skilled healthcare professionals, supports the dominance of this segment. Growing healthcare investments, expanding hospital networks, and rising awareness regarding early allergy detection are further driving demand for allergy diagnostic services within clinical settings. As the prevalence of allergic diseases continues to increase globally, hospitals and clinics are expected to remain key end users of allergy diagnostic products and services throughout the forecast period.

Looking for more specific insights? Customize this report to suite your business needs

Key Companies & Market Share Insights

The allergy diagnostics market is driven by a cohort of specialized diagnostics and biotechnology companies that are advancing the field through continuous innovation, technological advancements, strategic partnerships, and portfolio expansion across in vitro and in vivo allergy testing.

These companies are at the forefront of developing advanced allergy diagnostic solutions such as immunoassays, molecular allergy diagnostics, skin prick testing devices, and point-of-care testing platforms, addressing both respiratory and food allergies. For instance, in April 2025, Beckman Coulter Life Sciences announced the launch of its next-generation Basophil Activation Test (BAT), designed to enhance food allergy research by providing a safer and more efficient alternative to traditional testing methods. Similarly, HYCOR Biomedical continues to innovate with its NOVEOS System, focusing on automation and improved sensitivity in allergy testing. These ongoing innovations, coupled with strategic collaborations and regulatory approvals, are expected to drive significant advancements in the market, enabling earlier detection, better differentiation of allergens, and improved patient outcomes.

Key Allergy Diagnostics Companies:

• Thermo Fisher Scientific, Inc.
• HYCOR Biomedical
• EUROIMMUN Medizinische Labordiagnostika AG (PerkinElmer, Inc.)
• Omega Diagnostics Group PLC
• Lincoln Diagnostics, Inc.
• AESKU.GROUP GmbH
• Minaris Medical America, Inc.
• HOB Biotech Group Corp., Ltd.
• DASIT Group SPA
• R-Biopharm AG
• bioMérieux
• Siemens Healthcare GmbH

Explore Grand View Horizon to see global and regional level statistics related to the Allergy Diagnostics Market

Grand View Research offers

• Focused market intelligence reports on specific geographies or high-growth segments.
• Extended forecast timelines for long-term planning.
• Competitor Benchmarking and Supply Chain Analysis
• Inclusion of regulatory and policy assessments.
• Inclusion of custom data models, KPIs, or applications unique to your business
• Specific high-impact Data Decks and Tables to support effective decision making
• And much more…

Looking for a report customized to your requirements? Explore our Custom Research Offering